4 research outputs found
Baseline MDCT findings after prosthetic heart valve implantation provide important complementary information to echocardiography for follow-up purposes
Objectives: Recent studies have proposed additional multidetector-row CT (MDCT) for prosthetic heart valve (PHV) dysfunction. References to discriminate physiological from pathological conditions early after implantation are lacking. We present baseline MDCT findings of PHVs 6 weeks post implantation. Methods: Patients were prospectively enrolled and TTE was performed according to clinical guidelines. 256-MDCT images were systematically assessed for leaflet excursions, image quality, valve-related artefacts, and pathological and additional findings. Results: Forty-six patients were included comprising 33 mechanical and 16 biological PHVs. Overall, MDCT image quality was good and relevant regions remained reliably assessable despite mild-moderate PHV-artefacts. MDCT detected three unexpected valve-related pathology cases: (1) prominent subprosthetic tissue, (2) pseudoaneurysm and (3) extensive pseudoaneurysms and valve dehiscence. The latter patient required valve surgery to be redone. TTE only showed trace periprosthetic regurgitation, and no abnormalities in the other cases. Additional findings were: tilted aortic PHV position (n = 3), pericardial haematoma (n = 3) and pericardial effusion (n = 3). Periaortic induration was present in 33/40 (83 %) aortic valve patients. Conclusions: MDCT allowed evaluation of relevant PHV regions in all valves, revealed baseline postsurgical findings and, despite normal TTE findings, detected three cases of unexpected, clinically relevant pathology. Key Points: • Postoperative MDCT presents baseline morphology relevant for prosthetic valve follow-up. • 83 % of patients show periaortic induration 6 weeks after aortic valve replacement. • MDCT detected three cases of clinically relevant pathology not found with TTE. • Valve dehiscence detection by MDCT required redo valve surgery in one patient. • MDCT is a suitable and complementary imaging tool for follow-up purposes
Are novel non-invasive imaging techniques needed in patients with suspected prosthetic heart valve endocarditis? A systematic review and meta-analysis
Objectives: Multimodal non-invasive imaging plays a key role in establishing a diagnosis of PHV endocarditis. The objective of this study was to provide a systematic review of the literature and meta-analysis of the diagnostic accuracy of TTE, TEE, and MDCT in patients with (suspected) PHV endocarditis. Methods: Studies published between 1985 and 2013 were identified via search and cross-reference of PubMed/Embase databases. Studies were included if (1) they reported on the non-invasive index tests TTE, TEE, or MDCT; (2) data was provided on PHV endocarditis
Local Ultrasound-Facilitated Thrombolysis in High-Risk Pulmonary Embolism: First Dutch Experience
Purpose To provide insight into the current use and results
of ultrasound-facilitated catheter-directed thrombolysis
(USAT) in patients with high-risk pulmonary embolism
(PE).
Introduction Systemic thrombolysis is an effective treatment for hemodynamically unstable, high-risk PE, but is
associated with bleeding complications. USAT is thought
to reduce bleeding and is therefore advocated in patients
with high-risk PE and contraindications for systemic
thrombolysis.
Methods We conducted a retrospective cohort study of all
patients who underwent USAT for high-risk PE in the
Netherlands from 2010 to 2017. Characteristics and outcomes were analyzed. Primary outcomes were major
(including intracranial and fatal) bleeding and all-cause
mortality after 1 month. Secondary outcomes were allcause mortality and recurrent venous thromboembolism
within 3 months.
Results 33 patients underwent USAT for high-risk PE.
Major bleeding occurred in 12 patients (36%, 95% CI
22–53), including 1 intracranial and 3 fatal bleeding. Allcause mortality after 1 month was 48% (16/33, 95% CI
31–66). All-cause mortality after 3 months was 50% (16/
32, 95% CI 34–66), recurrent venous thromboembolism
occurred in 1 patient (1/32, 3%, 95% CI 1–16).
Conclusions This study was the first to describe characteristics and outcomes after USAT in a study population of
patients with high-risk PE only, an understudied population. Although USAT is considered a relatively safe
treatment option, our results illustrate that at least caution
is needed in critically ill patients with high-risk PE. Further
research in patients with high-risk PE is warranted to guide
patient selection
Conceptual model for early health technology assessment of current and novel heart valve interventions
Advances in the field of heart valve interventions, like tissue-engineered heart valves (TEHV). Prior to introduction in clinical practice, it is essential to perform early health technology assessment. We aim to develop a conceptual model (CM) that can be used to investigate the performance and costs requirements for TEHV to become cost-effective. Methods: After scoping the decision problem, a workgroup developed the draft CM based on clinical guidelines. This model was compared with existing models for cost-effectiveness of heart valve interventions, identified by systematic literature search. Next, it was discussed with a Delphi panel of cardiothoracic surgeons, cardiologists and a biomedical scientist (n=10). Results: The CM starts with the valve im